Facilitated By

San Antonio Medical Foundation

News

  • Zymeworks Announces Abstract for Zanidatamab in Late-Line HER2-Positive Breast Cancer ...

    ... Breast Cancer at the San Antonio Breast Cancer Symposium (SABCS) ... INDUSTRY KEYWORD: BIOTECHNOLOGY HEALTH PHARMACEUTICAL CLINICAL TRIALS ...

  • Oncolytics Biotech® to Present Phase 2 Triple-Negative Breast Cancer Trial Update at the ...

    (NASDAQ: ONCY) (TSX: ONC) today announced that the Company will present an update on the Phase 2 IRENE trial in a poster at the 2021 San Antonio ...

  • Context Therapeutics Reports Will Present Clinical Data On ONA-XR In Breast Cancer At ...

    ... Data On ONA-XR In Breast Cancer At San Antonio Breast Cancer Symposium Dec. ... The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, ...

  • San Antonio Dental Practice Wins Prestigious Awards for Clinical Excellence - PR Newswire

    PRNewswire/ -- New Image Dentistry has been given three major awards this year. The practice has been recognized as one of San Antonio's Top ...

  • City of San Antonio announces new utility assistance program - CPS Energy Newsroom

    City will provide eligible San Antonio residents with utility ... climate and growth opportunities in bioscience, financial services, aerospace, ...